TCM
CORT icon

Teza Capital Management’s Corcept Therapeutics CORT Stock Holding History

Teza Capital Management’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,088
Closed -$467K – 350
2025
Q1 		$467K Sell
4,088
-122
-3% -$7.43K 0.21% 156
2024
Q4 		$212K Buy
+4,210
New +$221K 0.03% 426
2024
Q2 		– Sell
-13,060
Closed -$329K – 606
2024
Q1 		$329K Buy
13,060
+6,624
+103% +$156K 0.04% 419
2023
Q4 		$209K Sell
6,436
-1,131
-15% -$31.1K 0.04% 494
2023
Q3 		$206K Buy
+7,567
New +$219K 0.03% 526
2020
Q3 		– Sell
-35,919
Closed -$604K – 418
2020
Q2 		$604K Buy
+35,919
New +$505K 0.13% 240
2020
Q1 		– Sell
-37,143
Closed -$449K – 202
2019
Q4 		$449K Buy
+37,143
New +$517K 0.12% 305

Other funds holding CORT

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.82B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.55B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return